Wenjun Yu1, Yijie Fang1, Qikun Guo2, Xiaojun Chen3, Wenhao Wu1, Long Qian4, Taoyu Jia5, Kunwei Li1, Chuan Huang6, Bing Wu4, and Shaolin Li1
1Radiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China, 2The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 3Radiology, The First Affiliated Hospital of Sun Yat-sen University, Zhuhai, China, 4MR Research, GE Healthcare, Beijing, Beijing, China, 5The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China, 6Radiology, Stony Brook Medicine, Stony Brook, New York, NY, United States
Synopsis
Liver
injuries have been reported with strong evidence in COVID-19 patients. Whether these disturbances are presented in
patients recovered from COVID-19 is still unknown. Totally 31 COVID-19
recovered patients were collected. And 37 sex- and age-matched normal controls
(NC) were were further recruited. MR imaging was performed using a 3.0T scanner
with T1mapping, R2* mapping and proton density fat fraction (PDFF) for all the
patients. Abnormal liver T1 and PDFF values, which may be associated with
subclinical renal injury due to COVID-19.
Introduction
Liver
injuries have been reported with strong evidence in COVID-19 patients. 1,2However,
for patients recovered from COVID-19, it is still unknown whether there is liver
damage or the extent of damage. This
research was to explore the value of T1 mapping, R2* mapping and proton density
fat fraction (PDFF) in the detection of subclinical liver injury in COVID-19
recovered patients and provide guidance for clinical diagnosis and treatment.METHODS
From
Feb 18, 2020 to Mar 5, 2020, totally 31 COVID-19 recovered patients were collected.
And 37 sex- and age-matched normal controls (NC) were were further recruited. MR
imaging was performed using a 3.0T scanner with T1mapping, R2* mapping and proton
density fat fraction (PDFF) for all the patients. T1, R2*, PDFF values were
measured independently by two radiologists. Intra-class correlation coefficient
(ICC) was used to evaluate the consistency between the two observers for each
subject. The comparisons of MRI indices between the NC (N = 31) and COVID-19 (N
= 31) groups were performed using independent two sample t-test or Mann-Whitney
U test, depending on the data distribution.. Partial correlation analysis was
applied to estimate the association between T1 and MRI-PDFF values in both
normal and COVID-19 groups with age and R2* as covariates.Results
The
ICC analysis of liver-lobe-based T1, PDFF and R2* measurements were shown excellent
repeatability. The T1 value of the COVID-19 patient group was lower than that
of the HC group, and the PDFF value was higher than that of the HC group.
Significant differences were identified in T1 and PDFF between COVID-19 group
and the HC group (P < 0.05). No significant difference was found in R2*
between COVID-19 group and the HC group (P > 0.05).Although liver T1 time is a maker of fibrosis, it can
be affected by other factors such as fat or iron. To verify whether the alteration of T1 values might be
affected by possibly existed liver inflammation or fibrosis, the partial
correlation between T1 and MRI-PDFF measures were performed with age and R2* as
covariates. The results of partial correlation analysis of liver
T1 and PDFF value in COVID-19 group was r=0.032, P = 0.8632 and HC group r =
-0.338, P = 0.0631DISCUSSION
Compared with healthy
volunteers, the T1 of convalescent patients with COVID-19 decreased and the
value of PDFF increased. Through the analysis of the correlation between liver
T1 value and PDFF, we found that there might be inflammation or fibrosis in the
liver of COVID-19 recovered patients. PDFF
can accurately reflects the concentration of triglycerides within the liver.3 IDEAL technology can provide PDFF without contamination due to field
inhomogeneity and has been widely used in the quantitative diagnosis of hepatic
steatosis.4Our PDFF result shows that there is a hepatic fat deposition in
COVID-19 recovered patients. The result of PDFF is consistent with the previous
pathological results. 5
T1 mapping can reflect small changes
in the T1 value within the tissue. 6Both the fat and iron have the opposing
effects on T1 time compared to fibrosis,7,8 hence it is challenging to speculate
whether the inflammation and fibrosis would be existed in liver. In our study,
the T1 value of COVID-19 group is lower than that of the HC group, which could
be accounted by hepatic steatosis. Also, the R2* values indicated that there
was no iron deposition in the liver. The partial correlation analysis indicated
that the negative association trend between the T1 and PDFF values in HC was
changed in COVID-19 group. This phenomenon might be associated with the
slightly invisible increased T1 value due to liver inflammation or fibrosis and
significantly observed decreased T1 value due to fat content.
conclusion
In conclusion, COVID-19-related liver
injury appears to manifest as steatosis of hepatocytes and possibly existed
liver inflammation or fibrosis. MRI-PDFF technique can not only detect early
COVID-19-related liver damage, but also provide a non-invasive method for
COVID-19 convalescent patients liver management.Acknowledgements
We thank all of the emergency services, nurses,
doctors, and other hospital staff for their efforts in fighting the COVID-19
outbreak. We also thank the nephrologists for collating and analyzing the
clinical data.References
1. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury
during highly pathogenic human coronavirus infections. Liver Int 2020.
https://doi.org/10.1 1 1 1/liv.14435 [Epub ahead of print].
2. Zhang C, Shi L, Wang F-S. Liver injury in COVID-19:
management and challenges. The Lancet Gastroenterology & Hepatology.
2020;5(5):428-30.
3. Idilman IS, Keskin O, Elhan AH, Idilman R,
Karcaaltincaba M. Impact of sequential proton density fat fraction for quantification
of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol
2014;49(5): 617–624.
4. Johnson BL, Schroeder ME, Wolfson T, Gamst AC,
Hamilton G, Shiehmorteza M, et al. Effect of flip angle on the accuracy and
repeatability of hepatic proton density fat fraction estimation by complex
data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson
Imaging. 2014;39(2):440-447.
5. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al.
Pathological findings of COVID-19 associated with acute respiratory distress
syndrome. The Lancet Respiratory Medicine. 2020;8(4):420-2.
6. Harrison SA, Dennis A, Fiore MM, Kelly MD, Kelly CJ,
Paredes AH, et al. Utility and variability of three non-invasive liver
fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with
NASH and bridging fibrosis during a phase-2 randomized clinical trial. PLoS
One. 2018;13(9):e0203054.
7. Mozes FE, Tunnicliffe EM, Pavlides M, Robson MD.
Influence of fat on liver T1 measurements using modified Look–Locker inversion
recovery (MOLLI) methods at 3T. Journal of Magnetic Resonance Imaging. 2016;
44:105–111.
8. Henninger B, Kremser C, Rauch S, Eder R, Zoller H,
Finkenstedt A, Michaely HJ, Schocke M. Evaluation of MR imaging with T1and T2* mapping
for the determination of hepatic iron overload. Eur. Radiol. 2012; 22(11):
2478–2486.